UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects

European journal of clinical pharmacology, 2012-05, Vol.68 (5), p.697-708

2012

Volltextzugriff (PDF)

Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects

Journal of translational medicine, 2014-12, Vol.12 (1), p.340-340, Article 340

2014

Volltextzugriff (PDF)

A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug-Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients

Drug metabolism and disposition, 2017-04, Vol.45 (4), p.361-374

2017

Volltextzugriff (PDF)

Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin

Drug metabolism and disposition, 2018-02, Vol.46 (2), p.109-121

2018

Volltextzugriff (PDF)

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor

Journal of clinical pharmacology, 2016-01, Vol.56 (1), p.78-86

2016

Volltextzugriff (PDF)

Pharmacokinetics of AXA1665, a Novel Composition of Amino Acids, in Comparison With Protein Supplement: A Single‐Dose, Open‐Label, Randomized Study in Healthy Subjects

Clinical pharmacology in drug development, 2023-07, Vol.12 (7), p.718-730

2023

Volltextzugriff (PDF)

Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase

Bioorganic & medicinal chemistry, 2005-04, Vol.13 (8), p.2723-2739

2005

Volltextzugriff (PDF)

Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

British journal of pharmacology, 2001-08, Vol.133 (7), p.1190-1198

2001

Volltextzugriff (PDF)

Disposition of morphine in plasma and cerebrospinal fluid varies during neonatal development in pigs

Journal of pharmacy and pharmacology, 2005-08, Vol.57 (8), p.981-985

2005

Volltextzugriff (PDF)

Abstract 7172: Pharmacokinetic/biomarker (PK/BMx) analysis of the toll-like receptor 7 and 8 (TLR7/8) agonist EIK1001 in phase 1 studies in participants (Pts) with solid tumors

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.7172-7172

2024

Volltextzugriff (PDF)

Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid

Journal of clinical pharmacology, 2016-03, Vol.56 (3), p.355-364

2016

Volltextzugriff (PDF)

Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants

Journal of clinical pharmacology, 2011-02, Vol.51 (2), p.218-228

2011

Volltextzugriff (PDF)

Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4[beta]-Hydroxycholesterol and Changes in Midazolam Exposure

Clinical pharmacology in drug development, 2016-07, Vol.5 (4), p.245

2016

Volltextzugriff (PDF)

Thrombostatin inhibits induced canine coronary thrombosis

Thrombosis and haemostasis, 1999-09, Vol.82 (3), p.1182-1187

1999

Volltextzugriff (PDF)

Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

European journal of clinical pharmacology, 2015-04, Vol.71 (4), p.425-432

2015

Volltextzugriff (PDF)

Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor

Clinical pharmacokinetics, 2015-07, Vol.54 (7), p.751-760

2015

Volltextzugriff (PDF)

Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure

Clinical pharmacology in drug development, 2016-07, Vol.5 (4), p.245-249

2016

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin

Journal of clinical pharmacology, 2014-07, Vol.54 (7), p.800-808

2014

Volltextzugriff (PDF)

Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents

Journal of pharmacological and toxicological methods, 2000-03, Vol.43 (2), p.101-116

2000

Volltextzugriff (PDF)

Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor

Clinical pharmacokinetics, 2015-07, Vol.54 (7), p.761-770

2015

Volltextzugriff (PDF)

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor: The Journal of Clinical Pharmacology

Journal of clinical pharmacology, 2016-01, Vol.56 (1), p.78-86

2016

Volltextzugriff (PDF)

Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis

Clinical and translational gastroenterology, 2020-08, Vol.11 (8), p.e00222-e00222

2020

Volltextzugriff (PDF)

Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects

International journal of clinical pharmacology and therapeutics, 2015-04, Vol.53 (4), p.317

2015

Volltextzugriff (PDF)

A semi-automated LC–MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014-06, Vol.960, p.182-193

2014

Volltextzugriff (PDF)

Effect of Cyclosporine on the Pharmacokinetics of Aliskiren in Healthy Subjects

Journal of clinical pharmacology, 2011-11, Vol.51 (11), p.1549-1560

2011

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(72)
Dissertationen
(1)

Sprache

Englisch
(73)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Pharmacology & Pharmacy
(41)
Male
(39)
Animals
(36)
Biological And Medical Sciences
(30)
Humans
(30)
Medical Sciences
(26)
Female
(24)
Pharmacology. Drug Treatments
(21)
Rats
(17)
Adult
(16)
Dogs
(16)
Middle Aged
(15)
Blood. Blood Coagulation. Reticuloendothelial System
(14)
Young Adult
(14)
Cardiovascular System & Cardiology
(13)
Drug Interactions
(12)
Disease Models, Animal
(10)
Rats, Sprague-Dawley
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects

Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects

A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug-Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients

Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor

Pharmacokinetics of AXA1665, a Novel Composition of Amino Acids, in Comparison With Protein Supplement: A Single‐Dose, Open‐Label, Randomized Study in Healthy Subjects

Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase

Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

Disposition of morphine in plasma and cerebrospinal fluid varies during neonatal development in pigs

Abstract 7172: Pharmacokinetic/biomarker (PK/BMx) analysis of the toll-like receptor 7 and 8 (TLR7/8) agonist EIK1001 in phase 1 studies in participants (Pts) with solid tumors

Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid

Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants

Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4[beta]-Hydroxycholesterol and Changes in Midazolam Exposure

Thrombostatin inhibits induced canine coronary thrombosis

Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor

Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure

Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin

Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents

Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor: The Journal of Clinical Pharmacology

Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis

Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects

A semi-automated LC–MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma

Effect of Cyclosporine on the Pharmacokinetics of Aliskiren in Healthy Subjects

Suchergebnisse filtern